Narayana Hrudayalaya Ltd Drops 5.4% as Valuation Premium Triggers, Profit Booking

Shares of Narayana Hrudayalaya Ltd. fell 5.38% on Tuesday to close at ₹1,981.40, amid sharp profit booking driven by valuation concerns and weakening technical indicators. The decline comes after a strong year-to-date rally of over 60%, far outpacing benchmark indices.

Elevated Valuation Draws Caution

Narayana Hrudayalaya Ltd share falling

Narayana Hrudayalaya currently trades at a PE multiple of 51.69, compared to an industry average of 43.16. Its price-to-book value stands at 11.26, and PEG ratio at 1.16, reflecting rich valuations relative to earnings growth. Despite robust operating metrics—ROE of 31.5%, ROCE of 27.7%, and a modest D/E ratio of 0.50—investors appear to be reassessing positions as the stock enters technically overbought territory.

Performance vs. Broader Market

PeriodNH ReturnNifty 50Nifty Pharma
1 Day-5.38%-0.35%+0.32%
3 Months+17.43%+9.09%+5.53%
1 Year+62.05%+5.51%+11.75%

The sharp divergence from broader indices adds to the thesis of short-term froth being corrected by market participants.

Weakening Delivery and Momentum Signals

A decline in delivery volumes supports the view of reduced long-term holding interest:

  • Daily delivery volume (Jul 1): 318.4K vs. 5-day avg of 407.1K (-21.8%)
  • Weekly delivery volume: down 33.1%
  • Monthly volume: down 92.2% compared to 5-month average

Despite strong medium-term momentum scores (67–75/100), the recent 7-day and 7-week trends show a downward shift, confirming short-term pressure.

Financials Remain Solid

MetricValue
Market Cap₹40,846 Cr
EV₹44,361 Cr
Net Sales (Q4FY25)₹1,475.44 Cr
EBITDA₹357.72 Cr
PAT₹153.86 Cr

The company continues to report consistent revenue and margin growth, underpinned by an asset-light model and expanding hospital network.

Outlook

The correction appears technical and valuation-driven, rather than fundamental. Unless broader sentiment deteriorates or valuations compress further, Narayana Hrudayalaya may find support near ₹1,950 levels. Investors should watch for recovery in delivery volumes and confirmation of support before reassessing entries.

Leave a Comment